These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3554657)

  • 1. Bone marrow transplantation for acute nonlymphoblastic leukemia during first complete remission. An analysis of prognostic factors.
    Forman SJ; Krance RA; O'Donnell MR; Nademanee AP; Snyder DS; Fahey JL; Schmidt GM; Zaia JA; Lipsett JA; Findley DO
    Transplantation; 1987 May; 43(5):650-3. PubMed ID: 3554657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors.
    Bostrom B; Brunning RD; McGlave P; Ramsay N; Nesbit M; Woods WG; Hurd D; Krivit W; Kim T; Goldman A
    Blood; 1985 May; 65(5):1191-6. PubMed ID: 3888309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
    Santos GW; Tutschka PJ; Brookmeyer R; Saral R; Beschorner WE; Bias WB; Braine HG; Burns WH; Elfenbein GJ; Kaizer H
    N Engl J Med; 1983 Dec; 309(22):1347-53. PubMed ID: 6355849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive therapy followed by bone marrow transplantation for patients with acute lymphocytic leukemia in second or subsequent remission: determination of prognostic factors (a report from the University of Minnesota Bone Marrow Transplantation Team).
    Woods WG; Nesbit ME; Ramsay NK; Krivit W; Kim TH; Goldman A; McGlave PB; Kersey JH
    Blood; 1983 Jun; 61(6):1182-9. PubMed ID: 6340756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia during first complete remission.
    Blume KG; Forman SJ; Snyder DS; Nademanee AP; O'Donnell MR; Fahey JL; Krance RA; Sniecinski IJ; Stock AD; Findley DO
    Transplantation; 1987 Mar; 43(3):389-92. PubMed ID: 3547796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.
    Coccia PF; Strandjord SE; Warkentin PI; Cheung NK; Gordon EM; Novak LJ; Shina DC; Herzig RH
    Blood; 1988 Apr; 71(4):888-93. PubMed ID: 3281725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias.
    Schmitz N; Gassmann W; Rister M; Johannson W; Suttorp M; Brix F; Holthuis JJ; Heit W; Hertenstein B; Schaub J
    Blood; 1988 Nov; 72(5):1567-73. PubMed ID: 3052626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow transplantation for children in first remission of acute nonlymphoblastic leukemia: an update.
    Sanders JE; Thomas ED; Buckner CD; Flournoy N; Stewart PS; Clift RA; Lum L; Bensinger WI; Storb R; Appelbaum FR
    Blood; 1985 Aug; 66(2):460-2. PubMed ID: 3893570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.).
    Zwaan FE; Hermans J; Barrett AJ; Speck B
    Br J Haematol; 1984 Apr; 56(4):645-53. PubMed ID: 6370297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated total body irradiation and high dose cyclophosphamide: a preparative regimen for bone marrow transplantation for patients with hematologic malignancies in first complete remission.
    Snyder DS; Findley DO; Forman SJ; Nademanee AP; O'Donnell MR; Schmidt GM; Bierman PJ; Fahey JL; Krance RA; Sniecinski IJ
    Blut; 1988 Jul; 57(1):7-13. PubMed ID: 3291991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Ringdén O; Labopin M; Tura S; Arcese W; Iriondo A; Zittoun R; Sierra J; Gorin NC
    Br J Haematol; 1996 Jun; 93(3):637-45. PubMed ID: 8652385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
    Yeager AM; Kaizer H; Santos GW; Saral R; Colvin OM; Stuart RK; Braine HG; Burke PJ; Ambinder RF; Burns WH
    N Engl J Med; 1986 Jul; 315(3):141-7. PubMed ID: 3523241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful allogeneic bone marrow transplantation for three children with acute nonlymphocytic leukemia.
    Ohira M; Takayama J; Hanada M
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():487-93. PubMed ID: 6097709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia.
    Forman SJ; Spruce WE; Farbstein MJ; Wolf JL; Scott EP; Nademanee AP; Fahey JL; Hecht T; Zaia JA; Krance RA; Findley DO; Blume KG
    Blood; 1983 Mar; 61(3):439-42. PubMed ID: 6337652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
    Storb R; Deeg HJ; Whitehead J; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Doney K; Farewell V
    N Engl J Med; 1986 Mar; 314(12):729-35. PubMed ID: 3513012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic bone marrow transplantation versus chemotherapy for childhood acute lymphoblastic leukaemia in second remission.
    Bacigalupo A; Van Lint MT; Frassoni F; Occhini D; Pittaluga PA; Comelli A; Dini G; Massimo L; Marmont AM
    Bone Marrow Transplant; 1986 May; 1(1):75-80. PubMed ID: 3332122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
    Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.